Sort
51,593 grants matching “hepatitis”
Adiponectin and CTRP9 signaling in muscle and liver
$714,404Harvey F Lodish · Whitehead Institute For Biomedical Res · R01 · FY2011 · DK
Molecularly Engineered Lectins for Intranasal Prophylaxis and Treatment of Coronaviruses
$714,193David Michael Markovitz · University Of Michigan At Ann Arbor · R01 · FY2025 · AI
Molecularly Engineered Lectins for Intranasal Prophylaxis and Treatment of Coronaviruses
$714,193David Michael Markovitz · University Of Michigan At Ann Arbor · R01 · FY2024 · AI
Project 2: RNA vaccination in early life to induce potent and broad HIV Env-specific antibody responses
$714,185Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
HIV, HCV, Hippo, and Liver Disease Progression
$714,134Raymond T Chung · Massachusetts General Hospital · R01 · FY2019 · AI
Effects of Anti-miR-33 on Atherosclerosis Regression and RCT in Nonhuman Primates
$713,949Ryan Eugene Temel · University Of Kentucky · R01 · FY2016 · HL
Alimentary Tract Lipids in Health and Disease
$713,868Brigham And Women'S Hospital · R37 · FY2004 · DK
Integrated vs. Separate Care for Hepatitis C, Substance Abuse, and HIV Prevention
$713,797Brian R. Edlin · Suny Downstate Medical Center · R01 · FY2010 · DA
QUS Technology for Diagnosis and Grading of Hepatic Steatosis in NAFLD
$713,773Claude B Sirlin · University Of California, San Diego · R01 · FY2015 · DK
The Progression of Hepatitis C Among IDUs
$713,629Johns Hopkins University · R01 · FY2002 · DA
Cytochrome P-450 Polymorphism
$713,598Eric F Johnson · Scripps Research Institute, The · R01 · FY2010 · GM
Pediatric Clinical Research Scholar Program - Washington
$713,540Naomi L Luban · Children'S Research Institute · K12 · FY2006 · RR
Reducing Youth Drug Related HIV/STD Risk in Thailand
$713,532Johns Hopkins University · R01 · FY2002 · DA
Molecular Magnetic Resonance Imaging of Inflammation
$713,467Eric Michael Gale · Massachusetts General Hospital · R01 · FY2025 · DK
Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease
$713,464Thorsten M Leucker · Johns Hopkins University · R01 · FY2025 · HL
Characterization of Genomics and Metabolomics among Individuals Highly-Exposed, but resistant to Mtb Infection
$713,405Neel Rajnikant Gandhi · Emory University · R01 · FY2019 · AI
Control of Viral Pathogenesis by Regulation of 2-5A Levels
$713,295Susan R. Weiss · University Of Pennsylvania · R01 · FY2016 · AI
Control of Viral Pathogenesis by Regulation of 2-5A Levels
$713,295Susan R. Weiss · University Of Pennsylvania · R01 · FY2017 · AI
Control of Viral Pathogenesis by Regulation of 2-5A Levels
$713,295Susan R. Weiss · University Of Pennsylvania · R01 · FY2015 · AI
Innate Immune Control of West Nile Virus
$713,273Michael J Gale · University Of Washington · R01 · FY2013 · AI
Association between pre-diagnosis hepatic fat infiltration and risk of liver metastasis and mortality in a large cohort of stage I-III colorectal cancer survivors
$713,116Edward Giovannucci · Harvard School Of Public Health · R01 · FY2022 · CA
Joint Initiative in Vaccine Economics (JIVE) Project
$712,764Tracy A Lieu · Harvard Pilgrim Health Care, Inc. · U01 · FY2006 · IP
Glycoprotein Remodeling in the Vasculopathy and Coagulopathy of Sepsis
$712,652Jamey Marth · University Of California Santa Barbara · R01 · FY2016 · HL
The Progression of Hepatitis C Among IDUs
$712,636David L Thomas · Johns Hopkins University · R01 · FY2008 · DA
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
$712,481Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · DK